Single arm open-label study to evaluate efficacy and safety of low intensity extracorporeal shockwave therapy in prostate cancer patients with ED after radical prostatectomy
Not Applicable
- Conditions
- Erectile dysfunction
- Registration Number
- JPRN-UMIN000022514
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient with spinal injury, chronic blood disease, and anatomic anomaly of penile vessels. 2) Patient with endocrine, mental or psychologic disease caused of erectile dysfunction. 3) Patients with past history of ischemic heart disease, cerebral hemorrhage, cerebral infarction and fetal arrhythmia, or who can not withdraw hemagogic drugs such as aspirin and warfarin. 4) Patients with cardiovascular disease prohibited to the sexual intercourse. 5) Patients have sexually transmitted infection and penile abscess. 6) Patients using nitrate drugs such as Nitroglycerin. 7) Patients judged not to appropriate to this study by the doctor in charge of this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess efficacy of low intensity extracorporeal shockwave therapy
- Secondary Outcome Measures
Name Time Method To assess safety of low intensity extracorporeal shockwave therapy